Dr Paul Baldock received his PhD in 2001 from the University of Adelaide, investigating the skeletal response to ovarian hormone deficiency with Professor Howard Morris. He then moved to the Garvan Institute in Sydney, where he is Head of the Skeletal Metabolism Group in the Osteoporosis and Bone Biology Division. He is a basic scientist, working with murine models of altered bone homeostasis. His research has focussed upon neuropeptide pathways: Demonstrating interactions between the brain and osteoblast in the control of bone mass. This work has defined novel links between bone, energy and glucose homeostasis. Most recently, his work has explored signalling from bone tissue, to regulate not only itself, but also aspects of energy and glucose homeostasis.